カテゴリ： DelveInsight, EP2016, 世界, 医療/バイオ

化学療法誘発性吐き気・嘔吐治療薬の世界市場：市場インサイト、疫学、市場予測

◆英語タイトル：Chemotherapy Induced Nausea and Vomiting  - Market Insights, Epidemiology and Market Forecast-2023
◆商品コード：DLVEP06043
◆発行会社（リサーチ会社）：DelveInsight
◆発行日：2016年9月
◆ページ数：約100
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後10営業日）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名使用）USD4,950 ⇒換算￥514,800見積依頼/購入/質問フォーム
Site Price（同一国内共有可）USD9,900 ⇒換算￥1,029,600見積依頼/購入/質問フォーム
Enterprise Price（複数国内共有可）USD14,850 ⇒換算￥1,544,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※DelveInsight社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
当調査レポートでは、化学療法誘発性吐き気・嘔吐治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。
・化学療法誘発性吐き気・嘔吐の概要
・病態生理
・化学療法誘発性吐き気・嘔吐の症状
・化学療法誘発性吐き気・嘔吐の病因
・化学療法誘発性吐き気・嘔吐の診断
・化学療法誘発性吐き気・嘔吐の治療
・上市品の概要
・医薬品の説明
・作用機序
・薬物動態学的特性
・特許情報
・化学療法誘発性吐き気・嘔吐の疫学分析
・化学療法誘発性吐き気・嘔吐治療薬の世界市場規模
・化学療法誘発性吐き気・嘔吐治療薬の世界市場予測
・化学療法誘発性吐き気・嘔吐治療薬のアメリカ市場規模
・化学療法誘発性吐き気・嘔吐治療薬のアメリカ市場予測
・化学療法誘発性吐き気・嘔吐治療薬のヨーロッパ市場規模
・化学療法誘発性吐き気・嘔吐治療薬のヨーロッパ市場予測
（ドイツ、イギリス、フランス、イタリア、スペイン）
・化学療法誘発性吐き気・嘔吐治療薬の日本市場規模
・化学療法誘発性吐き気・嘔吐治療薬の日本市場予測
【レポートの概要】

Note*: This report requires 7-10 business days to complete.

DelveInsight’s Chemotherapy Induced Nausea and Vomiting – Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chemotherapy Induced Nausea and Vomiting forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chemotherapy Induced Nausea and Vomiting till 2023.

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Chemotherapy Induced Nausea and Vomiting market.
• Identifying patient populations in the global “Chemotherapy Induced Nausea and Vomitingmarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Chemotherapy Induced Nausea and Vomiting therapeutics in each of the markets covered.
• To understand the future market competition in the global Chemotherapy Induced Nausea and Vomiting therapeutics market and Insightful review of the key market drivers and barriers.

Scope

• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Chemotherapy Induced Nausea and Vomiting for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

【レポートの目次】

Table of Contents

• Chemotherapy Induced Nausea and Vomiting overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Chemotherapy Induced Nausea and Vomiting Market
• Global Epidemiology of Chemotherapy Induced Nausea and Vomiting Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight

List of Tables

• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Chemotherapy Induced Nausea and Vomiting Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Chemotherapy Induced Nausea and Vomiting (2013-2023)
• Table 7: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2013-2015)
• Table 8: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2016-2023)
• Table 9: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2013-2015)
• Table 10: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2016-2023)
• Table 11: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2013-2015)
• Table 12: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2016-2023)
• Table 13: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2013-2015)
• Table 16: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2016-2023)
• Table 17: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2013-2015)
• Table 18: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2016-2023)
• Table 19: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2013-2015)
• Table 20: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2016-2023)
• Table 21: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2013-2015)
• Table 22: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2016-2023)
• Table 23: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2013-2015)
• Table 24: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2016-2023)

List of Figures

• Figure 1: Chemotherapy Induced Nausea and Vomiting Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Chemotherapy Induced Nausea and Vomiting (2013-2023)
• Figure 3: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2013-2015)
• Figure 4: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2016-2023)
• Figure 5: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2013-2015)
• Figure 6: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2016-2023)
• Figure 7: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2013-2015)
• Figure 8: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2016-2023)
• Figure 9: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2013-2015)
• Figure 12: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2016-2023)
• Figure 13: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2013-2015)
• Figure 14: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2016-2023)
• Figure 15: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2013-2015)
• Figure 16: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2016-2023)
• Figure 17: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2013-2015)
• Figure 18: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2015-2023)
• Figure 19: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2013-2015)
• Figure 20: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2016-2023)



【掲載企業】

• Acacia Pharma Ltd.
• Aphios Corporation
• Genovate Biotechnology Co. LTD.
• Helsinn Holding S.A.
• Heron Therapeutics Inc.
• INSYS Therapeutics Inc.
• Kyowa Hakko Kirin Co. Ltd.
• Merck & Co. Inc.
• RedHill Biopharma Ltd.
• Shin Nippon Biomedical Laboratories Ltd.
• Sparsha Pharma International Pvt. Ltd.
• Suda Ltd
• Teikoku Pharma USA Inc.
• Tesaro Inc.

【レポートのキーワード】

化学療法誘発性吐き気・嘔吐

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[化学療法誘発性吐き気・嘔吐治療薬の世界市場：市場インサイト、疫学、市場予測]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 化学療法誘発性好中球減少症治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06032 / DelveInsight / 2016年9月 / 当調査レポートでは、化学療法誘発性好中球減少症治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・化学療法誘発性好中球減少症の概要 ・病態生理 ・化学療法誘発性好中球減少症の症状 ・化学療法誘発性好中球減少症の病因 ・化学療法誘発性好中球減少症の診断 ・化学療法誘発性好中球減少症の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 7-10 business days to complete. DelveInsight’s Chemotherapy Induced Neutropenia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chemotherapy Induced Neutropenia forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chemotherapy Induced Neutropenia till 2023. Key Coverage and...
  2. ドライアイ治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06127 / DelveInsight / 2016年8月 / 当調査レポートでは、ドライアイ治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・ドライアイの概要 ・病態生理 ・ドライアイの症状 ・ドライアイの病因 ・ドライアイの診断 ・ドライアイの治療 ・上市品の概要 ・医薬品の説明 ・作用機序... Note*: This report requires 7-10 business days to complete. DelveInsight’s Dry eye disease - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Dry eye disease forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Dry eye disease till 2023. Key Coverage and...
  3. サルコペニア治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06038 / DelveInsight / 2016年9月 / 当調査レポートでは、サルコペニア治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・サルコペニアの概要 ・病態生理 ・サルコペニアの症状 ・サルコペニアの病因 ・サルコペニアの診断 ・サルコペニアの治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 7-10 business days to complete. DelveInsight’s Sarcopenia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Sarcopenia forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Sarcopenia till 2023. Key Coverage and Benefits • The report will help...
  4. てんかん治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06028 / DelveInsight / 2016年9月 / 当調査レポートでは、てんかん治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・てんかんの概要 ・病態生理 ・てんかんの症状 ・てんかんの病因 ・てんかんの診断 ・てんかんの治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 7-10 business days to complete. DelveInsight’s Epilepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Epilepsy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Epilepsy till 2023. Key Coverage and Benefits • The report will help...
  5. 脂質異常症治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06027 / DelveInsight / 2016年9月 / 当調査レポートでは、脂質異常症治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・脂質異常症の概要 ・病態生理 ・脂質異常症の症状 ・脂質異常症の病因 ・脂質異常症の診断 ・脂質異常症の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 5-10 business days to complete. DelveInsight’s Dyslipidemia - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Dyslipidemia forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Dyslipidemia till 2023. Key Coverage and Benefits • The report will help...
  6. 緑内障治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06022 / DelveInsight / 2016年9月 / 当調査レポートでは、緑内障治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・緑内障の概要 ・病態生理 ・緑内障の症状 ・緑内障の病因 ・緑内障の診断 ・緑内障の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 5-10 business days to complete. DelveInsight’s Glaucoma - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Glaucoma forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Glaucoma till 2023. Key Coverage and Benefits • The report will help...
  7. 副甲状腺機能亢進症治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06017 / DelveInsight / 2016年9月 / 当調査レポートでは、副甲状腺機能亢進症治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・副甲状腺機能亢進症の概要 ・病態生理 ・副甲状腺機能亢進症の症状 ・副甲状腺機能亢進症の病因 ・副甲状腺機能亢進症の診断 ・副甲状腺機能亢進症の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 5-10 business days to complete. DelveInsight’s Hyperparathyroidism - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Hyperparathyroidism forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Hyperparathyroidism till 2023. Key Coverage and Benefits • The report will help...
  8. 糸球体腎炎治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06170 / DelveInsight / 2016年8月 / 当調査レポートでは、糸球体腎炎治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・糸球体腎炎の概要 ・病態生理 ・糸球体腎炎の症状 ・糸球体腎炎の病因 ・糸球体腎炎の診断 ・糸球体腎炎の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 7-10 business days to complete. DelveInsight’s Glomerulonephritis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Glomerulonephritis for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Glomerulonephritis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Glomerulonephritis till 2023. Key Coverage and Benefits • The report will help in...
  9. 子宮内膜症治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06138 / DelveInsight / 2016年8月 / 当調査レポートでは、子宮内膜症治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・子宮内膜症の概要 ・病態生理 ・子宮内膜症の症状 ・子宮内膜症の病因 ・子宮内膜症の診断 ・子宮内膜症の治療 ・上市品の概要 ・医薬品の説明 ・作用機序... Note*: This report requires 7-10 business days to complete. DelveInsight’s Endometriosis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Endometriosis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Endometriosis till 2023. Key Coverage and Benefits • The report will help...
  10. 乾癬治療薬の世界市場：市場インサイト、疫学、市場予測
    DLVEP06078 / DelveInsight / 2016年9月 / 当調査レポートでは、乾癬治療薬の世界市場について調査・分析し、市場概要、医薬品概要、インサイト、疫学分析、市場規模予測データなどを含め、以下の構成でお届けいたします。 ・乾癬の概要 ・病態生理 ・乾癬の症状 ・乾癬の病因 ・乾癬の診断 ・乾癬の治療 ・上市品の概要 ・医薬品の説明 ・作用機序...Note*: This report requires 7-10 business days to complete. DelveInsight’s Psoriasis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Psoriasis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Psoriasis till 2023. Key Coverage and Benefits • The report will help...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆